SYNTHETIC BIOLOGICS INC (SYN) Stock Balance Sheet
NYSEARCA:SYN - NYSE Arca - US87164U4094 - Common Stock - Currency: USD
| MRQ (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 52.27M | 67.33M | 6.23M | 15.04M | 28.92M | |||
| Receivables | 278.00K | 0.00 | 469.00K | 3.00K | N/A | |||
| Other Current Assets | 2.34M | 1.53M | 1.24M | 1.38M | 593.00K | |||
| Total Current Assets | 54.89M | 68.86M | 7.93M | 16.43M | 29.51M | |||
| Non-Current Assets | ||||||||
| PPE Net | 22.14M | 1.48M | 453.00K | 786.00K | 607.00K | |||
| Goodwill | 5.18M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 119.00K | 23.00K | 23.00K | 23.00K | 23.00K | |||
| Total Non-Current Assets | 27.44M | 1.51M | 476.00K | 809.00K | 630.00K | |||
| TOTAL ASSETS | 82.33M | 70.36M | 8.41M | 17.23M | 30.14M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 56.00K | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 2.90M | 3.03M | 2.08M | 2.96M | 2.25M | |||
| Accounts Payable | 1.00M | 524.00K | 886.00K | 2.31M | 1.03M | |||
| Other Current Liabilities | 9.30M | N/A | N/A | 0.00 | 99.00K | |||
| Total Current Liabilities | 13.26M | 3.55M | 2.97M | 5.28M | 3.38M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 216.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 3.50M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 3.67M | 1.40M | 186.00K | 473.00K | 302.00K | |||
| Total Non-Current Liabilities | 7.39M | 1.40M | -2.59M | -2.40M | -2.61M | |||
| TOTAL LIABILITIES | 20.66M | 4.96M | 379.00K | 2.87M | 777.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -280.52M | -271.28M | -248.09M | -235.54M | -219.46M | |||
| Additional Paid In Capital | 343.50M | 336.56M | 240.82M | 232.58M | 230.75M | |||
| Minority Interest | N/A | 0.00 | -2.77M | -2.88M | -2.91M | |||
| Common Shares | 16.00K | 132.00K | 15.30M | 17.32M | 18.07M | |||
| Other Shareholders' Equity | -1.32M | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 15.84M | 13.20M | 2.92M | 1.68M | 1.55M | |||
| Tangible Book Value per Share | 3.57 | 4.95 | -2.48 | -1.75 | 7.30 | |||
| Total Shareholders' Equity | 61.67M | 65.41M | 8.03M | 14.37M | 29.36M | |||
| TOTAL LIABILITIES AND EQUITY | 82.33M | 70.36M | 8.41M | 17.23M | 30.14M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.14 | 19.37 | 2.67 | 3.11 | 8.72 | |||
| Return On Assets (ROA) | -21.59% | -20.28% | -119.42% | -88.79% | -44.35% | |||
| Return On Equity (ROE) | -28.82% | -21.81% | -125.05% | -106.53% | -45.52% | |||
All data in USD , ROIC based on taxRate of 0.21